March 20, 2012 – The Society for Cardiovascular Angiography and Interventions (SCAI) published a first-of-its-kind paper ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
In the past decade, there has been a major push toward minimally invasive cardiac procedures. In the cath lab ...
Management of coronary chronic total occlusion (CTO) is individualized depending on the severity of symptoms, ischemia ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Transcatheter heart valves are viewed as the poster children devices representing the latest in cutting-edge cardiac ...
March 16, 2012 -- Kensey Nash Corp. today announced that the company has entered into a $39 million settlement agreement ...
Hospitals that have built multimillion-dollar, specialized cardiovascular hybrid operating rooms (ORs) are hoping to ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
March 15, 2012 — According to Millennium Research Group (MRG) the interventional cardiology (IC) market in Pakistan ...
March 9, 2012 — Researchers say venom from the green mamba snake may aid in the preservation of cardiac and renal ...
March 9, 2012 — Avinger Inc. announced the enrollment of the first U.S. patient in the CONNECT II global clinical trial ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
March 7, 2012 — The U.S. Patent and Trademark Office (USPTO) granted biopharmaceutical development company BioLineRx for ...
March 1, 2012 – Steris Corp. announced they will collaborate with device manufacturer St. Jude Medical Inc. on the ...
February 28, 2012 — Janssen Research and Development LLC announced that the U.S. Food and Drug Administration (FDA) has ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
February 28, 2012 — AccessClosure Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of ...
February 24, 2012 — 3-D Surgical Solutions LLC and Wheaton Franciscan-The Wisconsin Heart Hospital Campus announced that ...
February 24, 2012 — A new report released today by HealthGrades found that from 2008 to 2010, emergency admissions for ...
March 20, 2012